17 May 2023
RNZ's Kathryn Ryan talks to our Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
Related articles
Tracking the journey of the shapeshifting bacteria behind stomach cancer
19 November 2025
Read more
Celebrating milestones in bringing life-saving cell therapies to New Zealand
12 November 2025
Read more
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Read more
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025
Read more
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Read more
Making local impact using global training in liver cancer research
30 October 2025
Read more